Ledger.Open graph →
SEC Form D · filed April 7, 2014

INTARCIA THERAPEUTICS, INC

Offering
$200.0M
Sold
$200.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Boston, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Brenda A. Cline · Dallas, TXDirectorGia Schneider · Alameda, CAExecRob C. Hart · San Francisco, CAExecLindsay Meyer · Palo Alto, CADirectorDomenic Merolla · Providence, RIExecTodd Kimmel · Palo Alto, CAExecMichael Novogratz · New York, NYDirector[Entity] Iri Cmif, LLC · Dallas, TXDirectorEthan Carlson · Providence, RIExecMichael Mars · Alameda, CAExec · DirectorPaul H. Hiyake · Los Angeles, CADirectorRobert A. Day · Los Angeles, CAExec · DirectorHoward M. Day · Los Angeles, CAExecJerry A. Carlton · Los Angeles, CAExec · DirectorDamon P. De Laszlo · Los Angeles, CADirectorRobert M. Miller · Los Angeles, CAExecRichard M. Morano Ii · CHATHAM, NJExecDonato A. Cuttone · CHATHAM, NJDirectorJoel Wolhendler · Lakewood, NJExec · DirectorAbraham Nekritz · Lakewood, NJExecDavid Franklin · Houston, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗